FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma
Naoyuki Okabe(Fukushima Medical University), Hiroyuki Suzuki(Kurume University)
Cited by 56
Related Papers
ADAM17 Mediates Epidermal Growth Factor Receptor Transactivation and Vascular Smooth Muscle Cell Hypertrophy Induced by Angiotensin II
|Arteriosclerosis Thrombosis and Vascular Biology|2006|46
Family with sequence similarity 83, member�B is a predictor of poor prognosis and a potential therapeutic target for lung adenocarcinoma expressing wild‑type epidermal growth factor receptor
|Oncology Letters|2017|10
Genomic Profiles of Pathogenic and Moderate-Penetrance Germline Variants Associated With Risk of Early-Onset Lung Adenocarcinoma
|Journal of Thoracic Oncology|2025|6